Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action
Andrew W Lindsley,1 Njira Lugogo,2 Kaitlin AG Reeh,3 Joseph Spahn,3 Jane R Parnes1 1Amgen Inc., Thousand Oaks, CA, USA; 2Michigan Medicine Asthma Program, University of Michigan, Ann Arbor, MI, USA; 3AstraZeneca, Gaithersburg, MD, USACorrespondence: Andrew W Lindsley, US Medical Affairs, Amgen Inc.,...
Saved in:
Main Authors: | Lindsley AW, Lugogo N, Reeh KAG, Spahn J, Parnes JR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-01-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/asthma-biologics-across-the-t2-spectrum-of-inflammation-in-severe-asth-peer-reviewed-fulltext-article-JAA |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tezepelumab for asthma with current or previous smoking habit: Case series
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-05-01) -
Biomarkers of type 2 and non-type 2 inflammation in asthma exacerbations
by: Kosar M. Ali, et al.
Published: (2024-07-01) -
Asthma and Atopic Diseases in Children with Autism Spectrum Disorders
by: Khaled Saad, et al.
Published: (2024-12-01) -
Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma
by: V. H. J. van der Velden
Published: (1998-01-01) -
Management of asthma in pregnancy
by: CE Jones, et al.
Published: (2025-01-01)